PeptidePedia The community reference

Contributions of RetatrutideRuben

User contributions·28 logged edits·page 1 of 1

Contributions by RetatrutideRuben, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 7,690 edits includes activity predating the current log.

  1. 15:33, 17 Jun 2026 (diff | hist) Talk:Retatrutide 885 +151 /* Heart-rate signal deserves more space */ reply
  2. 14:15, 8 Jun 2026 (diff | hist) Talk:TRIUMPH trial programme 748 +213 /* Heart-rate signal */ reply
  3. 09:35, 18 May 2026 (diff | hist) Talk:Amino acid analysis 537 +182 /* Value for compounds without a standard */ new section
  4. 15:48, 17 May 2026 (diff | hist) Dual incretin agonist 5,851 ±0 add the peptide length to the infobox
  5. 10:25, 26 Apr 2026 (diff | hist) Talk:Triple agonist 537 +143 /* Predicted failure mode */ new section
  6. 14:47, 3 Apr 2026 (diff | hist) Semaglutide 10,355 ±0 fix a dangling clause
  7. 12:40, 2 Mar 2026 (diff | hist) Talk:Retatrutide 611 +145 /* Phase 2 figures in the lead */ reply
  8. 22:27, 24 Feb 2026 (diff | hist) CagriSema 5,687 ±0 give the INN alongside the trade name at first mention
  9. 16:55, 22 Feb 2026 (diff | hist) Lixisenatide 4,195 ±0 add the excipient list from the labelling
  10. 16:08, 10 Feb 2026 (diff | hist) Amylin 5,795 ±0 add CAS number, sourced
  11. 11:45, 6 Oct 2025 (diff | hist) Custom peptide synthesis 4,773 ±0 rm the shipping recommendation — that is advice, not description
  12. 16:31, 27 Aug 2025 (diff | hist) ChinaPeptides 12,567 +60 m add the note that self-published material is usable only for what it states about itself
  13. 05:28, 18 Aug 2025 (diff | hist) GLP-1 receptor agonist 11,148 ±0 add see also to the amylin analogue
  14. 07:17, 29 Jul 2025 (diff | hist) Liraglutide 5,967 +152 m give the isoelectric point with the method it was determined by
  15. 20:18, 23 Jul 2025 (diff | hist) Trifluoroacetate counterion 4,865 +947 ce, tighten prose
  16. 19:56, 18 Jul 2025 (diff | hist) VendorInvestigate 5,067 +149 add the difference between a batch certificate and a lot-specific one
  17. 20:43, 25 Jun 2025 (diff | hist) Temperature excursion 10,953 +836 expand §Assessment and disposition
  18. 17:32, 31 May 2025 (diff | hist) Bachem Holding (Suzhou) 11,588 +1,223 serial comma per PP:MOS
  19. 16:00, 14 May 2025 (diff | hist) Wuhan Wansheng Biotechnology 11,331 +332 expand §Distribution and dispatch
  20. 21:13, 8 Apr 2025 (diff | hist) Arcuate nucleus 4,321 ±0 attribute the receptor-density claim to the tissue study it comes from
  21. 16:27, 3 Mar 2025 (diff | hist) Lixisenatide 3,215 +180 m convert a hard-coded date to the house format
  22. 15:32, 4 Feb 2025 (diff | hist) Underfilling 2,488 ±0 add the chain-of-custody point to §Limitations
  23. 16:58, 6 Jan 2025 (diff | hist) Insulin syringe unit conversion 3,086 ±0 state that the comparison is across trials and not head-to-head
  24. 05:06, 19 Dec 2024 (diff | hist) List of GLP-1 receptor agonists 2,866 +260 de-orphan
  25. 10:49, 3 Dec 2024 (diff | hist) Orforglipron 2,355 +781 m reorder the analogues chronologically rather than alphabetically
  26. 23:56, 29 Oct 2024 (diff | hist) Tirzepatide 4,989 +146 copyedit
  27. 00:01, 21 Aug 2024 (diff | hist) Subcutaneous injection 2,092 ±0 add the cross-link to the calculator page
  28. 22:30, 11 Aug 2024 (diff | hist) Glucagon 2,758 ±0 m expand §Secretion and its control